Company Search:
Advanced Search
Sponsored Links
AstraZeneca PLC - ADR Company Snapshot
AstraZeneca PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other companies in this sector in the United States: Abbott Laboratories (2016 sales of $20.85 billion of which 33% was Nutritionals), Eli Lilly and Company ($21.22 billion of which 38% was Endocrinology), and Teva Pharmaceutical Industries Limited ($21.90 billion of which 55% was Generic Madicines).

Sales Analysis. During the year ended December of 2016, sales at AstraZeneca PLC were $23.00 billion. This is a decrease of 6.9% versus 2015, when the company's sales were $24.71 billion.
  Stock Performance Chart for AstraZeneca PLC - ADR
  Stock Data: Recent Stock Performance:
  Current Price (11/17/2017): 33.46
(Figures in U.S. Dollars)
1 Week 1.7%   13 Weeks -3.4%  
4 Weeks 14.9%   52 Weeks 23.4%  
AstraZeneca PLC - ADR Key Data:
  Ticker: AZN Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 23,002,076,857
(Year Ending Jan 2017).
Employees: 59,700
  Currency: U.S. Dollars Market Cap: 84,717,294,901
  Fiscal Yr Ends: December Shares Outstanding: 2,531,897,636
  Share Type: Ordinary Closely Held Shares: 8,299,110
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.